title: Management of peri-implant mucositis and peri-implantitis.
abstract: Peri-implant diseases are defined as inflammatory lesions of the surrounding peri-implant tissues and include peri-implant mucositis (an inflammatory lesion limited to the surrounding mucosa of an implant) and peri-implantitis (an inflammatory lesion of the mucosa that affects the supporting bone with resulting loss of osseointegration). This review aims to describe the different approaches to manage both entities and to provide a critical evaluation of the evidence available on their efficacy. Therapy of peri-implant mucositis and nonsurgical therapy of peri-implantitis usually involve mechanical debridement of the implant surface using curettes, ultrasonic devices, air-abrasive devices or lasers, with or without the adjunctive use of local antibiotics or antiseptics. The efficacy of these therapies has been demonstrated for mucositis: controlled clinical trials show an improvement in clinical parameters, especially in bleeding on probing. For peri-implantitis, the results are limited, especially in terms of probing pocket-depth reduction. Surgical therapy of peri-implantitis is indicated when nonsurgical therapy fails to control the inflammatory changes. Selection of the surgical technique should be based on the characteristics of the peri-implant lesion. In the presence of deep circumferential and intrabony defects, surgical interventions should aim to provide thorough debridement, implant-surface decontamination and defect reconstruction. In the presence of defects without clear bony walls or with a predominant suprabony component, the aim of the surgical intervention should be the thorough debridement and the repositioning of the marginal mucosa to enable the patient to perform effective oral-hygiene practices, although this aim may compromise the esthetic result of the implant-supported restoration.
authors.forename: Elena
authors.initials: E
authors.lastname: Figuero
authors.forename: Filippo
authors.initials: F
authors.lastname: Graziani
authors.forename: Ignacio
authors.initials: I
authors.lastname: Sanz
authors.forename: David
authors.initials: D
authors.lastname: Herrera
authors.forename: Mariano
authors.initials: M
authors.lastname: Sanz
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods; D003646:Debridement / Q000379:methods; D015921:Dental Implants; D004203:Disinfection / Q000379:methods; D006801:Humans; D057873:Peri-Implantitis / Q000628:therapy*; D057747:Periodontal Debridement / Q000379:methods; D019651:Plastic Surgery Procedures / Q000379:methods; D013280:Stomatitis / Q000628:therapy*
chemical_list: D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D015921:Dental Implants